Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |